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Abstract 
 
Background: Loss of mobility is commonly reported by people with multiple sclerosis and can 
dramatically affect quality of life. Foot drop is a manifestation of the disease that increases fall risk. The 
purpose of this case report is to describe the clinical decision-making process used in determining the 
best method to correct foot drop for improving gait quality in a patient with multiple sclerosis. Case 
Description: This case examines a 67-year-old male with a history of primary progressive multiple 
sclerosis. He presented to therapy for this episode of care with functional foot drop and gait 
disturbances.  Intervention: The patient trialed two devices that are commonly prescribed to correct 
foot drop: the WalkAide functional electrical stimulation (FES) device and an ankle-foot orthosis (AFO). 
The patient began using the WalkAide device during therapy sessions focusing on gait training and also 
wore it when ambulating at home. Later in the episode of care, the patient switched to using an AFO 
during physical therapy and at home. Outcome Measures: The primary measures considered for this 
patient were the 6-minute walk test (6MWT), 10-meter walk test (10MWT), and the Berg balance score 
(BBS). The patient had a 120 feet improvement on the 6MWT at discharge. The patient showed an 
increase of 8 points on the BBS, signifying a noticeable improvement in balance. When directly 
comparing fast gait speeds with each device with the 10MWT, the patient was able to walk at 0.45 m/s 
with the AFO and 0.35 m/s with the WalkAide.  Discussion: This report supports the use of one of 
these devices to assist with foot drop as an adjunct to traditional physical therapy interventions in some 
patients with MS. The clinical decision between the devices should take into consideration objective 
measures of gait speed and balance, the observable kinematic effect on the ankle and knee, and the 
patient’s preference. The patient in this case ultimately preferred the AFO due to the stability it provided 
at both his ankle and knee.  
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Introduction: 
Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects more than 
900,000 people in the United States.1 Common characteristics include chronic inflammation, 
demyelination, gliosis (plaques or scarring), and neuronal loss, which can lead to a variety of clinical 
manifestations.  The factors that are most commonly reported to affect quality of life in this population 
are fatigue, balance and dizziness problems, and loss of mobility. These symptoms were reported in 
over 90% of respondents to a survey examining quality of life.2 Of the four types of MS, primary 
progressive accounts for only 10% of all cases and is characterized by a steady decline as the disease 
progresses.1 Medical treatment is limited for MS and there is a lack of research on proposed therapies. 
Symptomatic therapy is common and can include medications and physical therapy/exercise. 
Mobility is one of the most impactful factors when assessing quality of life in individuals with MS. 
Maintaining and supporting ambulation needs to be a focus of physical therapy interventions in this 
population.3 Motor deficits most commonly affect the lower extremities, with 85% of patients with MS 
reporting gait disturbances as their main complaint.4 Individuals with MS typically walk with a slow 
speed, shorter stride length, and longer double limb support phase.4 The energy cost of walking is 
greater for individuals with MS compared to the general population.5 Higher variability in stance time 
and step length have also been found to be correlated with a higher energy cost of walking along with 
higher levels of reported disability.5 Physical therapy interventions should aim to maintain mobility and 
reduce this energy cost by focusing on limiting gait variability.  
Reduced dorsiflexion at initial contact is a kinematic change commonly detected in gait in 
individuals with MS.3 This functional foot drop is a manifestation of the disease that affects gait quality 
and increases fall risk. Physical therapy interventions that focus on correcting foot drop include 
utilization of ankle-foot orthoses (AFO) and functional electrical stimulation (FES) devices.  The goal of 
these devices is to approximate a more normal gait pattern by correcting for dorsiflexion weakness, 
imbalances of eversion/inversion, and redirecting torque at the knee.  
Traditionally, passive dorsiflexion support during gait through the use of an AFO has been the 
treatment of choice for foot drop. AFOs have been shown to prevent foot drop throughout the gait cycle, 
reduce energy cost, enhance weight transfer over the weak leg, and improve ankle and knee 
kinematics in people with stroke.6 While there is an abundance of research supporting the use of AFOs 
in patients with stroke, there is limited conclusive research on the effects of AFOs in patients with MS 
despite it being common practice to prescribe these orthotics to this population.  One study examining 
the functional effect of AFOs in patients with MS found that there was no significant difference in gait 
velocity or performance on functional ambulation tasks when using an AFO compared to without the 
device.7 More research is needed to evaluate the effect of an AFO on energy cost and the 
biomechanics of gait in this population.   
More recently, FES devices have become increasingly available to promote active dorsiflexion 
during gait for patients with central neurologic diseases by stimulating the peroneal nerve. One 
example is the WalkAide device, which uses a tilt sensor to trigger an electrical stimulation during the 
swing phase.8 A meta-analysis concluded that FES used for foot drop had a positive initial and ongoing 
effect on gait speed in short walking tests (0.05 and 0.08m/s change respectively), but not on gait 
speed in long walking tests.9 However, using FES for foot drop provided no therapeutic effect on gait 
speed for either short or long walking tests.9 In another study, perceived exertion was lower for those 
using a WalkAide device compared to those using an AFO, yet energy consumption and metabolic 
efficiency did not vary between devices.10   
The choice of device to treat foot drop should take into consideration the patient’s preference. In 
a survey investigating individual’s subjective thoughts on the two devices, results showed variable pros 
and cons.11 Common perceived benefits of both devices were reduced fatigue, improved gait quality, 
reduced trips and falls, assistance on hills and stairs, increased participation in life, greater confidence, 
and less mental effort when walking. Common perceived shortcomings for the two devices included 
being uncomfortable, wanting to avoid reliance on device, inconvenient for shoes and clothing, and 
social barriers.11  
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While there is a large quantity of research supporting the use of these devices to target foot 
drop, there is a gap in the knowledge of how the kinematic differences between devices affect the 
individual’s quality of life and what role patient preference plays in deciding the best intervention. The 
purpose of this case study is to describe the clinical decision-making process used in determining the 
best method to correct foot drop for improving gait quality in a patient with MS.  
 
Case Description: 
The patient is a 67-year-old male, first diagnosed with primary progressive multiple sclerosis 
(PPMS) seventeen years prior at the age of 50. His symptom history included a gradual increase in 
ataxia, fatigue, lower extremity muscle tone, and lower extremity weakness that increasingly affected 
his daily functioning.  Twelve years after diagnosis, at 63 years of age he began walking with a cane for 
stability. He reported his functioning declined more rapidly three years ago (age 64) after a urinary tract 
infection resulting in a fall that led to a hospitalization. After this he purchased a power scooter for 
longer mobility distances.  
The patient has undergone three episodes of physical therapy care since his original diagnosis. 
All three involved concerns with his gait and fall history. Past therapists have tried many interventions to 
improve his foot drop including strength training and FES per patient report. The patient has tried to 
adopt a more active lifestyle and performs aquatic workouts three times per week, walks laps around 
his large shed (50 feet/lap) using a 4-wheeled walker (4WW), and has a home exercise plan that he 
has followed to maintain his strength. He presented to outpatient therapy for the current episode with 
ongoing concerns about his gait and balance. His chief concern was right lower extremity weakness 
and fatigue, that was the primary limiting factors of his mobility. He reported only walking household 
distances. He self-disclosed a significant fall history, reporting several falls in the last year. He reported 
his falls typically happen when his legs give out or if he catches his feet while walking. His primary goal 
of therapy was to be able to go on walks with his wife and pick up his grandkids. 
 
Clinical Impression 1: 
Reflecting on the initial information and history gathered, there were several factors that 
suggested the patient may be a strong candidate for gait training with either an AFO or a FES device. 
First, the patient reported occasionally catching his feet on the ground during gait leading to several 
falls. Gait devices have been shown to be effective at improving gait quality and functional foot drop in 
patients with central neurologic disorders.12 Second, the patient has maintained the ability to ambulate 
home distances so the disease has not progressed to the point of losing functional gait. Third, the 
patient was motivated to improve his gait quality, speed, and safety so that he could have a better 
quality of life.  
With these components in mind, the physical examination was designed to determine any 
strength or range of motion deficits, determine his tolerance of physical activity, and to rule in/out any 
conflicting diagnoses that would affect his ability to use a device for foot drop. Additionally, an area of 
consideration was the presence of lower extremity spasticity. This could greatly affect the patient’s 
ability to use a device and participate in gait training. 
 
Examination:  
The patient demonstrated passive range of motion (ROM) within functional limits (WFL) for 
bilateral lower extremities.  The patient did have excessive right knee hyperextension of 6 degrees. The 
patient exhibited strength impairments in bilateral lower extremities, with the right leg being weaker than 
the left leg. Per manual muscle testing, his right leg strength ranged from 2+/5 to 4/5 and his left leg 
strength ranged from 3+/5 to 5/5 (as shown in table 1). Of note, the patient had 3+/5 right ankle 
dorsiflexion strength. The patient also was found to have increased muscle tone according to the 
modified Ashworth scale. This was primarily found in his hamstrings (2/4 bilaterally) and hip adductors 
(right=2/4, left=1+/4). The patient reported normal sensation in bilateral lower extremities during a quick  
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sensory screen.  
The patient was independent with bed mobility and supine to sit transfers. He required standby 
assistance for sit to stand transfers and chair to bed transfers using a 4WW. He was able to ambulate 
200 feet with standby assistance and a 4WW. He 
presented with the following gait deviations: forward trunk 
posture, narrow base of support, decreased step length 
and height with the right lower extremity, hyperextension 
of the right knee during stance phase, diminished heel 
strike on right, and right toe drag during swing phase. The 
patient fatigued quickly, requiring a seated rest break 
after ambulation. The observed gait deviations increased 
with fatigue.  
The patient was unable to complete six continuous 
minutes of walking during the 6-minute walk test, walking 
200 feet with several losses of balance in just over 4.5 
minutes. His average gait speed was calculated at 0.22 
m/s according to the 6-minute walk test algorithm. The 
patient scored a 27/56 on the Berg balance test indicating 
that he was at a high fall risk. His performance on 
objective measures are detailed in Table 2 below in the outcome measures section. 
 
Clinical Impression 2: 
Based on the objective evaluation of the patient, he was an appropriate candidate for trial of an 
AFO or a FES device to correct his functional foot drop and improve his gait quality. He had no 
significant ROM deficits that would interfere with the application of the devices and he retained the 
strength to ambulate. He did, however, present with functional foot drop, weak dorsiflexors on his right 
lower extremity, and decreased clearance of his right foot during swing phase of gait. These 
characteristics made him an excellent candidate for one of these devices.6   
The plan of care for this patient was developed around gait and balance training to improve the 
quality and efficiency of his gait, as well as to decrease his fall risk. The objective measures were 
formally repeated during a re-evaluation after eight treatment sessions (about four weeks) and again at 
discharge after eight more sessions (about four weeks). In some instances, measures were reported 
during additional treatment sessions to compare his performance using an AFO versus a FES device. If 
the addition of an AFO or a FES device is effective, it is hypothesized that the patient’s performance on 
the 6-minute walk test would improve, along with an increase in gait speed, a decrease in observable 
gait deviations, and a decreased fall risk. 
 
Intervention: 
The patient received several interventions throughout his course of treatment including 
generalized strengthening, gait training, neuromuscular re-education, and aerobic endurance training. 
The patient was seen two times per week for 60-minute sessions for a total of 16 visits (about eight 
weeks).  
WalkAide: Gait training began immediately using a WalkAide FES device that was given to him 
during a previous episode of care several years ago. The patient reported only using it for a week 
before he was hospitalized for a medical issue and then did not use it after he returned home. He 
brought in the device and it was determined that the settings were not properly set for him.  After 
contacting WalkAide, a representative came and co-treated during a physical therapy session to 
calibrate the device appropriately. The parameters were adjusted to decrease the stimulation time to 
improve the timing of when the device is stimulating the tibialis anterior in relation to the swing phase. 
The WalkAide was placed on his right lower leg, just below his knee after wetting the electrodes and 
lining them up so that they are directly on the tibialis anterior muscle. The patient was prescribed a 1 
Table 1: Manual Muscle Test results 
 Right Left 
Hip Flexion 4- 4 
Hip Extension 3+ 3+ 
Hip Abduction 2+ 3+ 
Knee Flexion 4 4 
Knee Extension 4- 5 
Ankle Dorsiflexion 3+ 5 
Ankle Plantarflexion 4 5 
Ankle Inversion 4 5 
Ankle Eversion 4 5 
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hour wear schedule for the WalkAide at home for the first week. It was then increased by 30 minutes 
per day, which continued for 2 weeks. The device was utilized in therapy during those two weeks to 
accompany the other gait training tasks. The patient continued to report occasional catches of his toes 
on the ground with use of the device and was unable to control his right knee hyperextension, so it was 
determined that the patient may benefit from use of a solid AFO instead to provide more stability at the 
ankle and knee joints as well as increasing foot clearance during the swing phase. 
AFO: The patient was referred to a prosthetist for fitting for a custom solid AFO. The design 
included standard strapping with a lateral ankle strap position, full length foot plate, and was made out 
of 3/16” polypropylene. It took three weeks to fabricate the AFO and deliver it to the patient, so it was 
during week 5 of this episode that he began gait training with it. He was educated on donning and 
doffing the brace, the proper fit of the straps, and performing skin checks before and after use.  The 
patient was started on a wear schedule of 1 hour at a time. The patient self-accelerated this wear 
schedule by using it for four hours on day 2. In therapy, the patient continued working towards goals by 
completing more complex gait challenges and longer distance ambulation with the AFO donned.  
Other Interventions: Additional interventions were included in the plan of care to improve his 
strength, balance, and endurance. These included generalized strengthening of his lower extremities 
and trunk, neuromuscular re-education and high level dynamic balance exercises in standing, resisted 
ambulation, stair training, gait on uneven surfaces, cognitive tasks during gait, other complex gait tasks, 
and aerobic exercise on a Nustep recumbent stepper machine. These interventions were chosen to 
target specific areas of impairment that would improve the patient’s functional mobility and were 
prescribed appropriately to work towards his goals. They were adjusted as needed throughout the plan 
of care to optimize gait training and patient safety. The ultimate goal was to increase the efficiency of 
the patient’s gait to conserve energy and decrease fall risk. Although the conventional physical therapy 
interventions listed above are not the primary focus of this case report, they should not be overlooked 
as they were important in the overall physical recovery and improvements seen in this patient. 
 
Outcome Measures: 
The primary outcomes considered for this patient were the 6-minute walk test (6MWT), 10-
meter walk test (10MWT), and the Berg balance score (BBS). The 6MWT is a measure used to assess 
walking endurance and aerobic capacity. It involves the patient walking around a set perimeter for six 
minutes. The distance is measured and reported along with any assistive devices used. The patient is 
allowed to take a standing rest break but if they need to sit, the test is ended and the distance is 
recorded.  The BBS is used clinically to assess fall risk through static and dynamic balance activities. It 
involves a series of balance tasks that are scored on a scale from 0 to 4. Items are then added together 
and a total score is reported out of 56 points. The 10MWT measures gait speed over short distances. 
Walking speed has been linked to fall risk in older adults.13 A path of ten meters is marked on the 
ground with additional marks at two meters and eight meters. The patient walks the entire ten meters 
but the therapist measures the middle six meters for time. The stopwatch begins when any part of the 
patient crossed the two meter mark and ends when any part of the patient crosses the eight meter 
mark. The time is recorded in seconds. The patient should perform two trials at a preferred walking 
speed. Then the patient should perform two trials at a fast walking speed. To calculate the individuals 
preferred and fast speeds, divide six meters by the average time of the two trials calculated. A clinician 
should also document any assistance provided or any assistive device used during the test.  
The multiple sclerosis taskforce of the neurologic section of the American Physical Therapy 
Association highly recommends use of the 6MWT, 10MWT, and Berg balance test in the outpatient 
setting for this population.14 The 6MWT has excellent intra-rater and inter-rater reliability (0.97 and 
0.99) in the spinal cord injury (SCI) population. The 10 MWT has been shown to be reliable in both the 
SCI and the stroke population, with a test/retest between 0.94 and 0.99, intra-rater (0.87-0.95), and 
inter-rater (0.95-0.9). The Berg’s intra-rater, inter-rater, and test retest reliability are all 0.98.14 There is 
limited data published on the reliability of these tests for individuals with MS. The 6MWT and 10MWT 
have adequate to excellent validity, correlated with dependence in mobility (r=0.34-0.74) in individuals 
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with MS.15 Walking speed during the 6MWT and the 10 MWT are strongly correlated (r=0.95). The BBS 
was shown to have acceptable validity to discriminate fallers from nonfallers in the MS population 
however may have a ceiling effect so therapists should use caution.16 
Outcomes were reassessed at reevaluation (four weeks) and again at discharge (eight weeks) 
and are outlined in Table 2. The 10MWT was not tested as part of the initial and retest evaluations. This 
test was only used to compare the two foot drop interventions and is detailed in Table 3. The patient 
had a 120 feet improvement on the 6MWT at discharge. The MCID in stroke is 164 feet.14 The MCID for 
this BBS in the MS population is 3 points.14 The patient showed an increase of 8 points, signifying a 
noticeable improvement in balance in this patient. He was still at a high risk for falls supporting the use 
of a walker for all mobility. Taken together, the patient improved gait tolerance and balance during this 
episode of care.  
 
 When comparing his performance on standardized gait tests using each device, the patient did 
not use an assistive device during the initial evaluation, used the WalkAide during the four-week re-
evaluation, and used the AFO during the final assessment at discharge. It is difficult to determine 
whether the improvements seen were due to the different devices or the additional physical therapy 
interventions utilized in the plan of care. For that reason, it is challenging to compare the devices with 
these particular standardized outcome measures.  
During the last week of therapy, however, gait speed was measured with the 10MWT while the 
patient wore the AFO and then the WalkAide. The patient was able to walk slightly faster while wearing 
the AFO (0.31m/s) compared to the WalkAide (0.29m/s), which was most noticeable during the trials 
that the patient was walking as fast as he could (0.45 and 0.35 respectively). The MCID for the 10MWT 
in the SCI population is 0.6 m/s,14 indicating that this is a meaningful change. Both devices allowed the 
patient to walk significantly faster than at baseline (0.22m/s).  Directly comparing his observable gait 
quality in the devices also favors the AFO. Most notably the patient’s right knee hyperextension was 
resolved with the AFO, whereas it was inconsistent with the WalkAide. Subjectively, the patient 
preferred the AFO while walking because of the increased stability at the ankle that it provided. These 
comparisons are summarized in Table 3. 
 
Table 3: AFO vs WalkAide Comparison 
 AFO Walkaide 
Gait Quality Consistent step length on R 
Consistent clearance of R 
foot during swing phase 
Heel strike with R 
Neutral R knee position 
during stance phase 
Increased speed 
Heel strike with R 
Longer step length on R 
Occasional hyperextension of R knee 
during stance phase 
Increased speed 
*As patient fatigued, decreased 
clearance of R foot noted 
10-meter Walk Test 0.31 m/s normal speed 
0.45 m/s fast speed 
0.29 m/s normal speed 
0.34 m/s fast speed 
Patient subjective response “My foot feels secure and like 
I can trust it when I take a 
step” 
“It works well at first but when I use it 
for a long time I catch my foot on the 
ground again” 
Table 2: Objective measures results throughout episode of care 
Test Initial Evaluation (week 
0) 
Re-evaluation (week 4) Discharge (week 8) 
Berg Balance Test 27/56 31/56 35/56 
6-minute Walk Test 200 feet (stopped at 4 
min 35 sec) 
Did not formally assess 320 feet 
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Discussion: 
The purpose of this case study is to describe the clinical decision-making process used in 
determining the proper method for improving gait quality by correcting foot drop in a patient with MS. 
This report supports the use of a device to assist with foot drop as an adjunct to traditional physical 
therapy interventions. These individuals generally walk with a higher variability in step length, step 
height, and foot placement. They therefore utilize more energy during gait compared to a healthy 
control because they not only have to drive the center of mass forward, but have to correct for their 
irregular foot placements to increase stability during gait. This can play a role in the person’s fatigue 
levels and increase fall risk.15 With fatigue and mobility as two of the largest concerns for individuals 
with MS, therapy interventions should focus on decreasing step variability to conserve energy and 
improve mobility. AFOs and FES devices may be able to help provide consistency with gait mechanics 
through an ongoing orthotic effect, thus decreasing variability with ambulation.17  
Both devices assisted in addressing the target problem of foot drop and enhanced gait quality 
for this patient. When directly compared, the AFO appeared to improve ankle dorsiflexion at initial 
contact and prevented knee hyperextension where the WalkAide only addressed the dorsiflexion at the 
ankle and did not assist with knee kinematics. Also, the effects of the WalkAide seemed to diminish 
with fatigue as evident by the patient’s decreased clearance of his foot while walking. The potential 
benefits of FES on foot drop may be limited by the neurodegenerative nature of MS compared to a 
more stable neurologic condition like a stroke with residual weakness.9 Of note, the other gait training 
and strengthening interventions performed throughout the plan of care cannot be overlooked in 
explaining the progress seen in this patient. 
Ultimately, the patient in this case report ended up choosing to use the AFO for ambulation 
despite having access to both devices. This decision was based upon the objective improvement in gait 
speed and balance when wearing the device, the observable effect on both ankle and knee stability, 
and the patient’s preference. One might assume that an FES device would be superior as the more 
high-tech option that involves an active contraction that mimics “normal” walking.  However, each 
patient is unique and will require a personalized clinical decision-making process to assess needs. 
There are many factors not mentioned during this report, such as cost differential, appearance, and 
convenience that may play a role in the patient’s preference and the final decision.  
Many of the studies looking at the impact of FES devices and AFOs in the MS population do not 
specify the type of MS that the patients have. In one study, one quarter of participants did not benefit 
from FES devices, implying that there may be a subset of the population that doesn’t respond well to 
the intervention.10 More studies should investigate if there are any patterns with how individuals 
respond by type of MS diagnosis. It is possible that because the patient in this case report had primary 
progressive multiple sclerosis that he was less likely to respond to FES.2   
In summary, this report highlights that gait can improve with therapeutic intervention in patients 
with MS, and that while two different options to correct foot drop were helpful, one emerged to be the 
better choice for this patient. However, it cannot be determined that the improvements observed were a 
direct result of the interventions provided. It is important to analyze carefully the interventions chosen 
for physical therapy according to their effectiveness and how the patient is responding, and then make 
adjustments as necessary. This case illustrates the clinical decision-making process, showing that the 
best option may not be the first choice of the therapist, but may require some trial and error to achieve 
the best outcome for the patient. The combined treatment and foot drop interventions were safe and 
well tolerated in this patient. Further research is needed to establish guidelines to help therapists when 
deciding whether or not to add a device that targets foot drop into a physical therapy plan of care, 
considering type of MS, kinematic effects of the different devices, and patient preference. 
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